de Lannoy I A, Barker F, Pang K S
Department of Pharmacology, Faculty of Medicine, University of Toronto, Ontario, Canada.
J Pharmacokinet Biopharm. 1993 Aug;21(4):395-422. doi: 10.1007/BF01061689.
Single-pass and recirculating rat liver perfusion studies were conducted with [14C]enalapril and [3H]enalaprilat, a precursor-product pair, and the data were modeled according to a physiological model to compare the different biliary clearances for the solely formed metabolite, [14C]enalaprilat, with that of preformed [3H]enalaprilat. With single-pass perfusion, the apparent extraction ratio (or biliary clearance) of formed [14C]enalaprilat was 15-fold the extraction ratio of preformed [3H]enalaprilat, an observation attributed to the presence of a barrier for cellular entry of the metabolite. Upon recirculation of bolus doses of [14C]enalapril and [3H]enalaprilat, the biliary clearance, estimated conventionally as metabolite excretion rate/midtime metabolite concentration, for formed [14C]enalaprilat was again 10- to 15-fold higher than the biliary clearance for preformed [3H]enalaprilat, but this decayed with perfusion time and gradually approached values for preformed [3H]enalaprilat. The decreasing biliary clearance of formed enalaprilat with recirculation was explained by the dual contribution of the circulating and intrahepatic metabolite (formed from circulating drug) to excretion. Physiological modeling predicted (i) an influx barrier (from blood to cell) at the sinusoidal membrane as the rate-limiting process in the overall removal of enalaprilat, (ii) a 15-fold greater extraction ratio or biliary clearance for formed [14C]enalaprilat over [3H]enalaprilat during single-pass perfusion, and (iii) the time-dependent and declining behaviour of the biliary clearance for formed [14C]enalaprilat during recirculation of the medium. In the absence of a direct knowledge of eliminating organs in vivo, this variable pattern for excretory clearance of the formed metabolite within the organ is indicative of a metabolite formation organ.
使用前体 - 产物对[¹⁴C]依那普利和[³H]依那普利拉进行了单次通过和循环大鼠肝脏灌注研究,并根据生理模型对数据进行建模,以比较单独形成的代谢物[¹⁴C]依那普利拉与预先形成的[³H]依那普利拉的不同胆汁清除率。在单次通过灌注时,形成的[¹⁴C]依那普利拉的表观提取率(或胆汁清除率)是预先形成的[³H]依那普利拉提取率的15倍,这一观察结果归因于代谢物进入细胞存在屏障。在推注剂量的[¹⁴C]依那普利和[³H]依那普利拉循环后,按照传统方法将代谢物排泄率/代谢物浓度中位时间估算的胆汁清除率,对于形成的[¹⁴C]依那普利拉而言,再次比预先形成的[³H]依那普利拉的胆汁清除率高10至15倍,但这一数值随灌注时间衰减,并逐渐接近预先形成的[³H]依那普利拉的数值。形成的依那普利拉在循环时胆汁清除率降低,原因是循环中的代谢物和肝内代谢物(由循环药物形成)对排泄的双重作用。生理模型预测:(i)在肝血窦膜处存在流入屏障(从血液到细胞),这是依那普利拉整体清除过程中的限速步骤;(ii)在单次通过灌注期间,形成的[¹⁴C]依那普利拉的提取率或胆汁清除率比[³H]依那普利拉高15倍;(iii)在介质循环期间,形成的[¹⁴C]依那普利拉的胆汁清除率随时间变化且逐渐下降。在缺乏对体内消除器官的直接了解的情况下,器官内形成的代谢物排泄清除率的这种可变模式表明该器官是代谢物形成器官。